Singapore - English - HSA (Health Sciences Authority)

philips electronics singapore pte ltd - radiology / imaging - the magnetic resonance (mr) coil is intended to be used in conjunction with a mr scanner to produce diagnostic images of the anatomy of interest that can be interpreted by a trained physician.

Singapore - English - HSA (Health Sciences Authority)

ehc supply - dental - invivodental is a software application used for the display and 3d visualization of medical image files from scanning devices, such as ct, mri, or 3d ultrasound. it is intended for use by radiologists, clinicians, referring physicians, and other qualified individuals to retrieve, process, render, review, store, print, assist in distribute images, utilizing standard pc hardware. additionally, invivodental is a preoperative software application used for the simulation and evaluation of dental implants, orthodontic planning and surgical treatments. this device is not indicated for mammography use.

Singapore - English - HSA (Health Sciences Authority)

ehc commercial singapore pte. ltd. - dental - invivodental is a software application used for the display and 3d visualization of medical image files from scanning devices, such as ct, mri, or 3d ultrasound. it is intended for use by radiologists, clinicians, referring physicians, and other qualified individuals to retrieve, process, render, review, store, print, assist in diagnosis and distribute images, utilizing standard mac hardware. additionally, invivodental is a preoperative software application used for the simulation and evaluation of dental implants, orthodontic planning, and surgical treatments. this device is not indicated for mammography use.

Australia - English - Department of Health (Therapeutic Goods Administration)

aussia pharma - ascorbic acid, quantity: 50 mg; calcium pantothenate, quantity: 10 mg; vitis vinifera, quantity: 10 mg (equivalent: vitis vinifera, qty 1.2 g) - capsule, hard - excipient ingredients: colloidal anhydrous silica; microcrystalline cellulose; calcium hydrogen phosphate dihydrate; magnesium stearate; collagen; titanium dioxide; amaranth; tartrazine; brilliant blue fcf; purified water; gelatin; glycerol - antioxidant/reduce free radicals formed in the body ; maintain/support general health and wellbeing ; maintain/support nail health/strength/thickness ; maintain/support skin health ; maintain/support skin elasticity

Australia - English - Department of Health (Therapeutic Goods Administration)

penumbra neuro australia pty ltd -

Ireland - English - HPRA (Health Products Regulatory Authority)

apc pharmlog sp. z o.o. - cytisinicline - film-coated tablet - cytisinicline

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - varenicline tartrate, quantity: 1.71 mg (equivalent: varenicline, qty 1 mg) - tablet, film coated - excipient ingredients: calcium hydrogen phosphate; hypromellose; triacetin; hyprolose; titanium dioxide; indigo carmine aluminium lake; sodium stearylfumarate; croscarmellose sodium - varenicline tablets are indicated as an aid to smoking cessation in adults over the age of 18 years.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - varenicline tartrate, quantity: 1.71 mg (equivalent: varenicline, qty 1 mg) - tablet, film coated - excipient ingredients: hyprolose; titanium dioxide; hypromellose; triacetin; calcium hydrogen phosphate; indigo carmine aluminium lake; croscarmellose sodium; sodium stearylfumarate - varenicline tablets are indicated as an aid to smoking cessation in adults over the age of 18 years.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - deferasirox, quantity: 360 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; crospovidone; povidone; magnesium stearate; colloidal anhydrous silica; poloxamer; hypromellose; titanium dioxide; macrogol 4000; purified talc; indigo carmine aluminium lake - the treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adults and paediatric patients 6 years and older. deferasirox sandoz is also indicated for the treatment of chronic iron overload in paediatric patients aged 2 to 5 years who are unable to take desferrioxamine therapy or in whom desferrioxamine has proven ineffective. deferasirox sandoz is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older.